These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. AgNOR counts have no prognostic value in breast cancer. Toikkanen S, Joensuu H. J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490 [Abstract] [Full Text] [Related]
23. Argyrophilic nucleolar organizer regions in Wilms' tumors and related lesions: a histologic and chromosomal correlation. Mourad WA, Lavallee-Grey M, Pappenhausen P, Essig YP, Rowlands DT. Mod Pathol; 1991 Mar; 4(2):247-52. PubMed ID: 1646458 [Abstract] [Full Text] [Related]
24. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications. Bànkfalvi A, Ofner D, Schmid KW, Schmitz KJ, Breukelmann D, Krech R, Böcker W. Pathol Res Pract; 1999 Mar; 195(4):219-29. PubMed ID: 10337659 [Abstract] [Full Text] [Related]
25. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa. Piffkò J, Bànkfalvi A, Ofner D, Rasch D, Joos U, Schmid KW. Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314 [Abstract] [Full Text] [Related]
26. [Study on diagnostic value of analyzing argyrophilic nucleolar organizer regions in benign and malignant pleural effusions]. Jiang S, Zeng Z, Liao Z. Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):34-6. PubMed ID: 11263298 [Abstract] [Full Text] [Related]
27. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice. Kodousek R, Dusek J. Acta Univ Palacki Olomuc Fac Med; 1991 Jan; 131():9-37. PubMed ID: 1726500 [Abstract] [Full Text] [Related]
28. [Prognostic value of AgNORs in breast cancer]. Aubele M, Auer G, Jütting U. Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674 [Abstract] [Full Text] [Related]
30. Quantitative evaluation of AgNORs in bone tumours. Arora B, Jindal K, Kumar S, Rekhi B, Arora H, Arora DR. Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456 [Abstract] [Full Text] [Related]
31. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer]. Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sowa M. Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994 [Abstract] [Full Text] [Related]
33. AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from south India. Subramanian S, Shariff S, Andrade C. J Surg Oncol; 1996 Jun; 62(2):139-43. PubMed ID: 8649041 [Abstract] [Full Text] [Related]
35. [Quantitative study on nucleolar organizer regions in salivary gland tumours]. Wang SZ. Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):74-6, 127. PubMed ID: 1337733 [Abstract] [Full Text] [Related]
36. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy. Lim SM, Duggan MA, Ruff M, Rahim S, McGregor SE, Green FH. J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274 [Abstract] [Full Text] [Related]
37. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Uporov AV, Tsyrlina EV, Pozharisskiĭ KM. Vopr Onkol; 1998 Jan; 44(3):316-24. PubMed ID: 9695779 [Abstract] [Full Text] [Related]
38. [Silver-stained Nucleolar Organizer Regions (AgNOR)]. Derenzini M, Trerè D. Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299 [Abstract] [Full Text] [Related]